|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o ARC Pharmaceuticals Inc., of Vancouver, British Columbia, presented data at the 21st annual meeting of the European Society of Human Reproduction and Embryology in Copenhagen, Denmark, showing that cisplatin-loaded films can reduce adhesion formations following pelvic or abdominal surgery in women. Those adhesions represent a significant cause of decreased reproductive potential.
o Callisto Pharmaceuticals Inc., of New York, said it received orphan drug designation in the U.S. for Annamycin to treat acute lymphoblastic leukemia. The second-generation anthracycline was developed at M.D. Anderson Cancer Center. Callisto plans to begin a clinical trial in adult ...
Related newspaper, magazine, and journal articles:
|
|
Article: BIOGEN IDEC CUTTING STAFF TO REDUCE COSTS, TIGHTEN ...
BIOWORLD Today;
September 12, 2005 ;
700+ words
... ... issues. (See BioWorld Today, June 20, 2005.) Biogen Idec also is seeking ... of strength." Biogen Idec reported net income ... effort to position Biogen Idec for the years 2010 ... Juves told BioWorld Today. "It will provide ...
|
|